Dementia / Alzheimer's Prevention - Part 2
- Dr. Thomas J. Lewis
- Mar 27
- 8 min read
Here is a link to the Rumble video - Dementia / Alzheimer's Prevention - Part 2
Quick recap
By the time you have symptoms of mild cognitive impairment, you have already lost:
8% of your total brain volume
15% of your hippocampus
The meeting focused on dementia prevention and discussed various approaches, including early diagnosis, microbial pathogens, and treatment strategies. Dr. Carter presented on the hallmarks of Alzheimer's disease, explaining how amyloid and tau proteins function as antimicrobial peptides and energy-conserving molecules, respectively.
Marvin shared research on photobiomodulation's effectiveness in reducing phosphorylated tau and beta-amyloid proteins in mouse models. The discussion covered diagnostic tools, including CNS vital signs testing, eye examinations, and quantitative EEG for brain function assessment.
Participants also explored treatment pathways under the RIDER acronym (Repair, Immunity, Detox, Energy, and Regulatory) and discussed the importance of micronutrients, healthy fats, hormone optimization, and immune support.
The conversation included practical advice on testing for intracellular pathogens such as Chlamydia pneumoniae and Mycoplasma, as well as recommendations for hormone replacement therapy for both men and women.
Summary
Dementia Prevention Sugar Alternatives Discussion
The group discussed sugar alternatives for a dementia-prevention project, with Dr. Carter providing detailed information on stevia processing and blends containing erythritol. Michael suggested triolose as a good sugar alternative, while Dr. Lewis shared his experience using honey in an enema bottle for long rides.
Alzheimer's Disease Protein Mechanisms
The discussion focused on the hallmarks of Alzheimer's disease, particularly the roles of amyloids and tau proteins. Dr. explained that amyloids are antimicrobial peptides and tau microfibrillary tangles protect against hypoxic tissue, drawing parallels to energy storage in hibernating animals. The conversation also touched on the use of GDX instruments to measure tau levels and the one-for-one congruence between amyloid plaquing in the eye, brain, and cerebral spinal fluid, as demonstrated by research at Harvard.
Amyloid Peptides and Alzheimer's Research
Dr. discussed the connection between amyloid peptides and their role in both antimicrobial defense and potential links to Alzheimer's disease. They highlighted the importance of early diagnosis in dementia prevention, noting that substantial brain and hippocampus loss can occur years before symptoms appear. Dr. emphasized the need for comprehensive diagnostic approaches, including cognition testing, blood testing, and eye exams, to accurately assess cognitive health and detect potential issues early. The discussion also touched on the presence of intracellular pathogens like Chlamydia pneumoniae, which may contribute to metabolic changes in infected cells and could play a role in neurodegenerative conditions.
Cell Death and Pathogen Detection
Dr. discussed the process of apoptosis in cells and how delayed cell death can lead to the accumulation of sick, old cells in the body. Marvin presented research on photobiomodulation, showing significant reductions in phosphorylated tau and beta-amyloid proteins in mouse models after treatment with 1070 nanometer light. Dr. emphasized the importance of detecting intracellular pathogens and explained the three phases of Chlamydia pneumoniae, highlighting the challenge of detecting non-active "sleeper cells" in the body.
Brain Health and Disease Insights
The discussion focused on the complexities of brain health and disease, particularly regarding hippocampus volume loss and the role of focal infections. Dr. explained that while AI may not always provide accurate assessments, there are effective interventions, such as mindfulness meditation, that can increase brain volume, including in the hippocampus and hypothalamus. The conversation also addressed the challenges of detecting systemic immune responses in blood tests for localized infections, particularly in the eye, and emphasized the importance of considering both terrain and pathogens in health approaches.
Immune System and Brain Function
Dr. discussed the importance of understanding the body's terrain and immune system, particularly in relation to oral pathogens and their impact on energy levels as people age. He explained Ewald's classification of non-self organisms into three categories: mutualistic, commensal, and parasitic, and emphasized the role of immune-supporting peptides for those over 60. The discussion concluded with a conversation about quantitative EEG (QEEG) as a tool for assessing brain function, with Marvin offering to help clients find locations for acute EEG testing or provide equipment for at-home testing.
QEEG Testing and Clinical Applications
The discussion focused on QEEG testing and its clinical applications. Marvin explained that while comparing brain activity to normative databases has limitations, QEEG can effectively measure an individual's power and connectivity for clinical interventions. Dr. discussed his approach to testing for various health issues including Lyme disease, intracellular parasites, and inflammation markers, and outlined his protocol for improving fibrinogen as an inflammation signal molecule. The conversation also touched on brain imaging techniques and the potential connection between delivery methods and temple spots visible in QEEG results. Dr. introduced two frameworks for understanding disease mechanisms - AMIS (autophagy, micronutrients, subacute infections, stress) and RIDER (repair, immunity, detox, energy, regulatory), indicating plans to explore these further in future discussions about dementia prevention.
Insulin Resensitization Treatment Approach
The doctor discussed physiological insulin resensitization as an alternative to standard insulin therapy for patients with diabetes, emphasizing the importance of regulatory mismatch in diabetes management. They highlighted the benefits of micronutrients and healthy fats, referencing historical data on Victorian diets and the role of cholesterol in human health. The doctor stressed that cholesterol is essential for various bodily functions, including hormone production, and recommended flooding the system with micronutrients and healthy fats as a first step in addressing health issues.
Health and Wellness Strategies Discussion
Dr. discussed health and wellness strategies with Marvin, focusing on liver health, LDL cholesterol, and detoxification methods. Dr. advised against lowering LDL levels and recommended niacin protocols, liver detoxes, and proper drainage for brain health. They also discussed insulin resistance, the dangers of aggressive insulin therapy, and the benefits of physiological insulin resensitization. Dr. mentioned overseeing 40-day fasts but suggested starting with shorter fasts for beginners. The conversation concluded with a discussion on photobiomodulation's ability to enhance brain energy metabolism and cellular function, and Dr. emphasized the importance of optimal hormone levels, suggesting using an averaged range from multiple sources rather than standard care reference ranges.
Immune Support and Dementia Prevention
Dr. discussed the importance of immune support in dementia prevention, highlighting immunosenescence as a key aging-related pathway. The discussion included questions about hormone levels and their impact on dementia risk, with Dr. and Michael providing insights on testosterone and estrogen replacement therapy for women over 80. The conversation ended with a brief discussion about red light therapy for hair growth, where Marvin recommended a minimum of 24 watts of LED power for effectiveness.
Dementia / Alzheimer's Prevention - Part 1
Here is a link to the video on this topic.
The meeting focused on Dr. Lewis' presentation on dementia prevention and early detection, in which he discussed how lifestyle factors and underlying infections contribute to neurodegenerative diseases.
Dr. Lewis explained that early detection through cognitive testing and eye exams is crucial, as brain atrophy can begin years before clinical symptoms appear. He emphasized that while there's no true prevention, catching dementia early enough to address underlying causes like inflammation and infection is key. The presentation covered how beta-amyloid acts as an antimicrobial peptide and how tau hyperphosphorylation serves as a protective mechanism in response to hypoxia. Dr. Lewis recommended basic testing, including cognitive assessments, blood work, and eye exams, while noting that conventional medical treatments often overlook the root causes of dementia.
AI Summary
Neurodegenerative Disease Detection and Research
Dr. Thomas discussed the similarities between different neurodegenerative diseases, emphasizing that while they affect different parts of the brain, the underlying processes are often similar. He highlighted the importance of early detection, using glaucoma as an example of an early warning sign for Alzheimer's. Dr. Thomas explained that dementia is best understood as a syndrome rather than a single disease, and he emphasized the interconnectedness of various health conditions. He also introduced the concept of hallmarks in neurodegenerative diseases, such as beta amyloid, and discussed the potential of using peptides to treat inflammation and support immunity. Dr. Carter corrected Dr. Thomas, noting that beta amyloid is an antimicrobial peptide. The discussion concluded with a focus on the use of optical coherence tomography (OCT) to detect neurodegenerative changes in the eye, which can be an early indicator of brain changes.
Neurodegenerative Disease Misconceptions Discussion
Dr. Thomas discussed the misconceptions around neurodegenerative diseases, emphasizing that they are not infectious in the traditional sense but can be triggered or accelerated by viral and bacterial infections. He challenged the notion that these diseases are primarily genetic, citing evidence that suggests lifestyle factors, such as physical activity and diet, play a significant role in their prevalence. Dr. Thomas also highlighted the importance of early detection and maintaining a healthy lifestyle to prevent or delay the onset of neurodegenerative diseases.
Neurological Links to Dementia Risk
Dr. Thomas discussed the link between neurological issues, depression, and anxiety to increased risk of Alzheimer's and dementia, citing a Danish cohort study showing a 2.5 times higher hazard ratio for dementia in people with depression. He emphasized the importance of early cognitive monitoring, particularly for those over 40, and highlighted that conditions like depression and anxiety are associated with an increased risk of dementia. Dr. Thomas also mentioned a study showing up to 15% atrophy in the hippocampus before cognitive impairment diagnosis, advocating for more effective screening methods beyond the limited mini-mental state exam.
Cognitive Function Testing Discussion
Dr. Thomas and Michael Carter discussed cognitive function tests, focusing on the CNS Vital Signs test, which Dr. Thomas recommended for assessing cognitive impairment. They criticized the standard psychiatric approach to cognitive issues, highlighting limitations in current treatments and diagnostic tools. Dr. Thomas expressed concerns about the overuse of SSRIs and monoclonal antibodies in treating cognitive disorders, emphasizing the need for better diagnostic methods and treatments.
Brain Function Diagnostic Tools Discussion
The group discussed various diagnostic tools for brain function assessment, with Dr. Thomas expressing a preference for quantitative EEG over functional images, while Dr. Harvey emphasized the importance of the QEEG program used and shared his experience with the Bender Gestalt test, which he found valuable despite his initial skepticism. They also reviewed laboratory tests for dementia, noting that while these tests can identify hallmarks like amyloid beta and tau, none directly address the root cause of neurodegeneration, leading Dr. Thomas to question the current recommendation against routine MCI diagnosis due to potential overdiagnosis, when underdiagnosis may be a greater issue.
Alzheimer's Research and Detection Methods
Dr. Thomas discussed the potential role of beta-amyloid 142 as an antimicrobial peptide, referencing research by Robert Moyer and Rudolf Tanzi at Harvard. He highlighted the work of Judith McClosie, who demonstrated a causal link between ketosis and Alzheimer's disease, and mentioned the involvement of various researchers in studying the connection between bacterial infections and Alzheimer's. Dr. Thomas also touched on the controversy surrounding the approval of a drug for Alzheimer's and the possibility of using eye exams as an early detection method for the disease.
Eye-Brain Condition Correlation Research
Dr. Thomas discussed the correlation between eye and brain conditions, particularly supranuclear cortical cataracts and Alzheimer's plaques, and highlighted the potential of using a slit-lamp microscope for early diagnosis, despite the lack of reimbursement codes for more advanced instruments like the MP-1. He emphasized the challenges of fighting medical dogma and the need for further studies to establish causation, mentioning his research on hyperphosphorylated tau in hibernating animals and its potential link to local hypoxia and energy conservation in the brain.
Hypoxia and Tau in Dementia
Dr. Thomas discussed the relationship between hypoxia and tau hyperphosphorylation in the brain, explaining that while this mechanism provides protection in hibernating animals, it may contribute to dementia in humans due to reduced local oxygen levels despite normal blood oxygen saturation. He criticized current Alzheimer's therapies that target tau hyperphosphorylation, noting that TauRx's failure in clinical trials was predictable given this understanding. Dr. Thomas emphasized the importance of early testing for dementia through basic measures like eye exams, blood tests, and CNS vital signs, and suggested that lifestyle factors such as reduced micronutrient intake and increased inflammation contribute significantly to dementia risk.
Be bold and brave. Fight the dogmas!
Comments